Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Triclabendazole (CGA89317) has been used in trials studying Parasitic Disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 44.00 | |
50 mg | In stock | $ 63.00 | |
100 mg | In stock | $ 79.00 | |
200 mg | In stock | $ 102.00 | |
500 mg | In stock | $ 167.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Triclabendazole (CGA89317) has been used in trials studying Parasitic Disease. |
In vitro | Triclabendazole treatment produces percentage decreases of the fluke egg output by 15.3%, 4.3% and 36.6%, respectively, in sheep, dairy cows and heifers, these results indicate the presence of TCBZ-resistant Fasciola hepatica in sheep and cattle on this farm. [1] Triclabendazole sulphoxide (50 mg/mL) results in extensive damage to the tegument of triclabendazole-susceptible F. hepatica, whereas triclabendazole-resistant flukes shows only localized and relatively minor disruption of the tegument covering the spines. [2] |
Synonyms | CGA89317 |
Molecular Weight | 359.66 |
Formula | C14H9Cl3N2OS |
CAS No. | 68786-66-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 67 mg/mL (186.3 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Triclabendazole 68786-66-3 Cytoskeletal Signaling Microbiology/Virology Microtubule Associated Parasite Inhibitor CGA-89317 Microtubule/Tubulin CGA 89317 inhibit CGA89317 inhibitor